PLUS1
13.56
0.14 (1.04%)
0.14 (1.04%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SWK Holdings Corporation | SWKH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.14 | 1.04% | 13.56 | 15:41:51 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 13.40 | 12.80 | 13.60 | 13.42 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 13.60 | 13.79 | 0.19 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 164 | 12,154 | $ 13.18 | $ 160,129 | 9,188 | 6.12 - 16.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:41:43 | 1 | $ 13.675 | USD |
SWK Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 173.43M | 12.79M | 3.51M | $ 30.75M | $ 664.14k | 1.85 | 18.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 12.80% |
SWK News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/12/2021 | 08:30 | PR Newswire (US) | Enteris BioPharma to Host Webinar on Strategies for.. |
| 1/07/2021 | 08:00 | PR Newswire (US) | Enteris BioPharma Highlights 2020 Achievements and 2021.. |
| 1/04/2021 | 16:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 1/04/2021 | 15:56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 1/04/2021 | 15:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 1/04/2021 | 15:43 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 1/04/2021 | 15:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SWKH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.88 | 13.9701 | 12.80 | 13.34 | 5,733 | -0.32 | -2.31% |
| 1 Month | 14.72 | 15.05 | 12.80 | 14.03 | 7,273 | -1.16 | -7.88% |
| 3 Months | 13.22 | 15.35 | 12.5802 | 14.42 | 9,020 | 0.34 | 2.57% |
| 6 Months | 12.59 | 16.24 | 12.17 | 14.19 | 10,755 | 0.97 | 7.7% |
| 1 Year | 14.00 | 16.24 | 6.12 | 13.47 | 12,601 | -0.44 | -3.14% |
| 3 Years | 14.00 | 16.24 | 6.12 | 13.47 | 12,601 | -0.44 | -3.14% |
| 5 Years | 14.00 | 16.24 | 6.12 | 13.47 | 12,601 | -0.44 | -3.14% |
SWK Description
| SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables; Pharmaceutical Development Services and others. It generates maximum revenue from the Finance Receivables segment. |
